From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs. To justify the costs of drug development, most pharmaceutical companies ...

This real-world data can be instrumental in shaping future research and refining the drug development process. Pharmaceutical companies ... clinical trials and EAPs have a consistent flow of ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

China NMPA grants marketing approval to CANbridge’s velaglucerase-beta for injection to trat Type I and III Gaucher disease: Suzhou, China Monday, May 19, 2025, 14:00 Hrs [IST] ...

Veeva Systems today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, ...

Zura Bio Limited ("Zura Bio" or the "Company"), a clinical-stage, multi-asset immunology company dedicated to developing novel dual-pathway antibodies for a range of autoimmune and inflammatory ...

Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...

HEPZATO launch shows strong revenue growth, profitability, and U.S. expansion, marking a biotech turning point. Read why DCTH ...